Hydroxychloroquine and azithromycin
Jump to navigation
Jump to search
Hydroxychloroquine and azithromycin together are being studied as a possible cure for the covid-19 plague.
- “We urgently need a safe and effective treatment for COVID-19. Repurposing existing drugs is an attractive option because these medications have undergone extensive testing, allowing them to move quickly into clinical trials and accelerating their potential approval for COVID-19 treatment,” said NIAID Director Anthony S. Fauci, M.D.
- Although there is anecdotal evidence that hydroxychloroquine and azithromycin may benefit people with COVID-19, we need solid data from a large randomized, controlled clinical trial to determine whether this experimental treatment is safe and can improve clinical outcomes.”[1]
References
- ↑ [NIH begins clinical trial of hydroxychloroquine and azithromycin to treat COVID-19 https://www.nih.gov/news-events/news-releases/nih-begins-clinical-trial-hydroxychloroquine-azithromycin-treat-covid-19] - Study enrolling adults with mild to moderate COVID-19 in the United States, announced Thursday, May 14, 2020